Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease
Clinical trial NCT00322868 · COMPLETED
Trial details
- NCT number
- NCT00322868
- Sponsor
- University Hospitals Cleveland Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2006-12-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.